Introduction
Avian influenza viruses present a permanent threat to the poultry industry and give rise to newly emerging human strains that may cause devastating pandemics. Efficient control of these viruses and the disease they cause is still not feasible. New insights into the complexity of influenza viruses and their life cycle are required to promote the design of novel antiviral substances and effective vaccines. A promising approach is to take advantage of the power of the innate immune system and to identify host cell factors that block influenza virus growth. The authors and others have studied the interferon-(IFN-) regulated Mx system. Mx genes were originally found to confer resistance against influenza virus infection in mice (14, 26, 45) . Related genes have now been described in many species. Mx proteins are large GTPases that work intracellularly and abort influenza virus growth by blocking the viral transcription and/or replication machinery in infected cells (16, 17) . In this paper, the authors review the properties of Mx proteins and discuss their role in host defence against highly pathogenic viruses. Moreover, it is proposed that mammalian Mx proteins may normally provide a barrier against zoonotic transmission of avian influenza A viruses (FLUAV) and that the extent of acquired resistance to the antiviral action of human MxA may be one of many factors which facilitate the spread of pandemic influenza virus strains.
Induction of the anti-viral interferon response by influenza A virus
Interferon was originally discovered and characterised as an antiviral cytokine during experiments with FLUAV in chicken cells (19) . Much progress has since been made in understanding how type I (␣/␤) and type III (λ) IFN are induced by distinct viruses and how they act in mammalian cells (Fig. 1) . It is now clear that conserved molecular signatures of viruses are recognised by specialised receptors of the host cell (Fig. 1a) . These 'danger signals' consist of viral single-stranded ribonucleic acid (RNA) genomes containing a 5´-triphosphate group (3, 18, 33) . Alternative danger signals are double-stranded (ds) RNA molecules (formed as RNA intermediates during virus replication) and deoxyribonucleic acid (DNA) of viral or microbial origin. The viral RNA is detected by retinoic acid-inducible gene-I-(RIG-I-) like receptors (RLR) in the cytoplasm or by Toll-like receptors (TLR) in the endosome. Retinoic acid-inducible gene-I senses the genomes of influenza viruses and other negative-strand RNA viruses, whereas melanoma differentiation-associated gene 5 is mainly involved in recognition of positive-strand RNA viruses. These RLR then trigger a series of signalling events that lead to the co-ordinate activation of transcription factors, such as interferon regulatory factor 3 (IRF-3) and nuclear factor kappa B (NF-κB), which culminates in the induction of type I (␣/␤) and type III (λ) IFN (Fig. 1 ).
For proper signalling, the adaptor molecule, induced pluripotent stem cell-1 (IPS-1), also called mitochondrial anti-viral signalling protein (MAVS), found inserted in the mitochondrial outer membrane and additional membrane protein(s), plays a crucial role. Its membrane topography presumably helps to form a large and stable complex into which the kinases IκB kinase epsilon (IKKε)κ and tumour necrosis factor receptor-associated factor (TRAF) family member-associated NF-κB activator-(TANK-) binding kinase 1 (TBK-1) are recruited. These kinases eventually phosphorylate IRF-3. Phosphorylated IRF-3 homo-dimerizes and moves into the nucleus, where it induces the formation of an enhanceosome complex that includes additional transcriptional activators. Together these transcription factors strongly up-regulate expression of type I and type III IFN genes.
Once secreted from the producer cells, the various type I IFN subspecies bind to and activate a common receptor, IFN-␣/␤ receptor (IFNAR), whereas type III IFN activates a different receptor (IFN-λ receptor [IFNLR] , also designated IL28R) (Fig. 1b) . Both receptors signal to the nucleus through the Janus-activated kinase (JAK) signal transducers and activators of transcription (STAT) pathway, which is well characterised (24, 34, 47, 49 ) and so will not be discussed here.
Interferon-induced proteins with antiviral activity against influenza A virus
Type I and type III IFN activate the expression of an overlapping set of IFN-stimulated genes (ISG), some of which have antiviral activity (Fig. 1b) . Three enzyme systems represent major antiviral pathways that have been extensively studied. These include:
-the dsRNA-dependent serine/threonine protein kinase R (PKR) (50) -the dsRNA-dependent 2´-5´ oligoadenylate synthetase (OAS)/RNase L system (41) -the Mx GTPases (13, 16).
Mice lacking one or several of these pathways show increased susceptibility to many viruses, including FLUAV (51) . Additional proteins with potentially important antiviral activities are as follows:
Influenza A virus is probably affected by many of these factors. However, the Mx GTPase is presently considered to be the major effector molecule inhibiting influenza virus growth in IFN-treated cells, as shown below.
Countermeasures of influenza A virus against the interferon response of the host
Most pathogenic viruses have evolved ways to escape the antiviral IFN and cytokine responses of the host. Successful pathogens display numerous escape strategies, allowing them to: -suppress IFN production -down-modulate IFN signalling -block the action of antiviral effector proteins (for comprehensive reviews, see 15, 35) .
In many instances, IFN-antagonistic functions are mediated by non-structural (NS) viral proteins. These NS proteins are produced abundantly in infected cells but are not noticeably incorporated into virus particles. In essence, they function early in infection and prepare the cell for optimal virus replication by interacting with multiple cellular and viral factors. The decisive NS protein of FLUAV is NS1. It is a small dsRNA-binding protein with distinct functional domains, which are involved in regulating a number of crucial events during FLUAV replication (for a comprehensive review, see 12). The NS1 protein enhances virus growth by activating phosphatidylinositol 3-kinase signalling and by modulating viral messenger RNA (mRNA) translation. Importantly, NS1 has been identified as the prototype IFNantagonistic factor that blocks the production and action of IFN (Fig. 1) . As a multifunctional protein, NS1 exerts anti-IFN activity in various ways. For example, NS1 is thought to bind and sequester dsRNA and to form a complex with RIG-I, thereby preventing downstream signalling (Fig. 1a) . 
The Mx GTPase family
Sensitivity to the inhibitory action of Mx GTPases is a characteristic property of all orthomyxoviruses, including influenza A, B and C, Thogoto virus and infectious salmon anaemia virus. In the mouse, the Mx1 protein is the main factor mediating the inhibition of influenza viruses by IFN (45) . The first evidence for an Mx-related protein in humans was obtained with a monoclonal antibody against mouse Mx1 that cross-reacted with an IFN-induced protein in human cells (43) . Subsequently, two human Mx genes were identified and shown to code for two cytoplasmic proteins called MxA, 76 kilodaltons (kDa), and MxB (73 kDa), respectively (1). The available sequence data reveal considerable conservation among Mx proteins from different vertebrate species. In most instances, at least two genes were identified. Polymorphisms have been reported, predominantly for chicken and porcine Mx genes (32, 39) . Vertebrate Mx proteins can be grouped into five subgroups, according to their sequence similarities (Fig. 2) . These comprise the avian, fish and rodent subgroups, as well as an MxA-like and MxB-like subgroup. Interestingly, the antivirally active huMxA protein is more closely related to the canine, porcine, bovine, ovine and equine Mx1 proteins, than to its non-antiviral huMxB counterpart, which clusters with the respective Mx2 proteins of other species.
Fig. 2 Phylogenetic tree of Mx proteins
The Mx proteins are grouped into five subgroups, according to their sequence similarities. Sequences were obtained from GenBank and aligned with ClustalW version 1.81. The tree was constructed using the DrawGram function of the Biology WorkBench 3.2. The following sequences were used for the alignment: human MxA (huMxA, A33481), human MxB (huMxB, P20592), dog Mx1 (caMx1, AAF44684), dog Mx2 (caMx2, AF239824), pig Mx1 (poMx1, P27594), pig Mx2 (poMx2, A7VK00), bovine Mx1 (boMx1, P79135), bovine Mx2 (boMx2, AF355147), sheep Mx1 (ovMx1, P33237), sheep Mx2 (ovMx2, Q5I2P5), horse Mx1 (eqMx1, Q28379), horse Mx2 (eqMx2, XP_001491517), mouse Mx1 (muMx1, NP_034976), mouse Mx2 (muMx2, NP_038634), rat Mx1 (ratMx1, NP_775119), rat Mx2 (ratMx2, NP_599177), cotton rat Mx1 (crMx1, DQ218274), cotton rat Mx2 (crMx2, DQ218273), chicken Mx (chMx, Q90597), duck Mx (duMx, P33238), turkey Mx (turMx, ABQ43205), rainbow trout (rtMx1, AAA87839), Atlantic salmon Mx1 (asMx1, NP_001117165), Atlantic halibut Mx (ahMx, AAF66055), zebra fish Mx (zfMx, NP_891987), and disk abalone shell Mx (abaMx, ABI53802)
Properties of Mx GTPases
The Mx proteins share many structural and functional properties with the high molecular weight GTPases of the dynamin superfamily. They have a GTPase domain at the N-terminus, a 'central interactive domain' in the middle, and an effector domain with leucine zipper motifs at the C-terminal end (Fig. 3) . The N-terminal region contains the tripartite GTPase domain and is highly conserved, whereas the C-terminal region is divergent and involved in viral target recognition. A single amino acid exchange, E645R, in the effector domain of MxA, specifically abolishes the antiviral activity of MxA against some (but not other) viruses, suggesting that the effector domain recognises viral target structures in a specific manner (52) . Interestingly, a non-synonymous substitution (S631N) in the effector domain of the chicken Mx protein (Fig. 3) has been identified and proposed as a determinant of antiviral activity (21, 22) , a finding which is under somewhat controversial discussion at present (see below). The Mx GTPases self-assemble into highly ordered oligomers, which presumably represent stable intracellular storage forms from which antivirally active monomers are recruited for prolonged periods of time (13) .
with membranes of the smooth endoplasmic reticulum, such as huMxA (Fig. 4) . In contrast, rodent Mx1 proteins are nuclear, forming characteristic dots (Fig. 4) . Interestingly, the subcellular localisation of rodent Mx proteins largely determines their antiviral specificities. Thus, nuclear Mx1 proteins inhibit orthomyxoviruses, known to replicate in the cell nucleus, whereas cytoplasmic Mx2 proteins inhibit rhabdoviruses and bunyaviruses, known to have a cytoplasmic replication phase (Table I) . Also of interest is the fact that cytoplasmic human MxA protein has antiviral activity against a wide range of RNA and some DNA viruses, irrespective of their subcellular site of replication. An antiviral role has also recently been described for Mx proteins of fish. Atlantic salmon Mx1 inhibits the influenza-like infectious salmon anaemia virus and also infectious pancreatic necrosis virus, an aquatic birnavirus (23) . Data obtained with avian Mx proteins are limited and will be discussed below.
Antiviral spectrum of Mx GTPases and mechanism of action
The mechanism of Mx action has been studied for a number of viruses but is still not completely understood. Mx proteins were found to bind to essential viral components and block their functions. A physical interaction with the nucleoprotein component of viral nucleocapsids was demonstrated for orthomyxoviruses and bunyaviruses. A mini-replicon system was used in which recombinant nucleocapsids of FLUAV were reconstituted from cloned complementary DNA (cDNA) (Fig. 5a ). In this system, co-expression of a reporter minigenome, together with the polymerase sub-units (PA, PB1 and PB2) and the viral nucleoprotein (NP), leads to the assembly of nucleocapsids. These viral nucleocapsids are also called viral ribonucleoprotein complexes (vRNP) and are transcriptionally active in the cell nucleus. Human MxA and mouse Mx1 were able to interfere with the transcriptional activity of reconstituted vRNP. Interestingly, the inhibitory activity of both Mx proteins was determined by the virus origin. Avian FLUAV strains were more sensitive to inhibition by Mx1 or MxA than human strains. Figure 5b shows a comparison of two highly pathogenic FLUAV; namely, an avian H5N1 strain isolated from a fatal case in Vietnam (A/Vietnam/1203/04) and the pandemic H1N1 strain of 1918 (A/BM/1/18). The mini-replicon systems of both viruses were inhibited by mouse Mx1 (left panel) or human MxA (right panel), but the amount of Mx protein needed for inhibition differed greatly. Clearly, both Mx proteins inhibited polymerase activity of the avian strain more efficiently than that of the human strain, and the same was true for additional virus strains tested (8) .
The viral determinant of sensitivity towards Mx proteins appeared to be the viral nucleoprotein, rather than the polymerase complex itself. The deliberate exchange of the avian NP-encoding plasmid with the human counterpart converted a sensitive avian polymerase into a more resistant one, and vice versa (8) . These findings suggest that NP is the target structure of Mx. Nevertheless, how exactly Mx GTPases prevent nucleocapsid function at the molecular level is still a matter for investigation. It is thought that Mx GTPases probably recognise the multimeric lattice of NP on the viral nucleocapsids and immobilise these structures by wrapping around them in a dynamin-like way (13) .
Presently available data also suggest that human MxA may provide an efficient block to zoonotic transmission of avian FLUAV, including H5N1 viruses that presently circulate in Southeast Asia. Resistance to Mx may be one of many genetic traits an avian virus has to acquire to gain pandemic potential in humans. When BALB/c mice, with or without functional Mx1 alleles, were infected with highly pathogenic FLUAV, the outcomes were dramatically different. Groups of Mx1 +/+ and Mx1 -/-mice were challenged with 10 LD 50 (i.e. doses which were lethal for 50% of the study group) for BALB/c mice of A/Vietnam/1203/04. This avian strain and other highly virulent H5N1 strains are known to cause a systemic infection in standard inbred strains of laboratory mice (40) . However, weight loss was moderate in the Mx1 +/+ group and all animals survived. In contrast, all Mx1 -/-mice developed severe disease and succumbed to infection between day four and day seven after infection, as expected (Fig. 5c ). Likewise, functional Mx1 genes also protected mice against the pandemic human 1918 influenza virus (48) , despite the generally lower sensitivity of human strains to the antiviral action of Mx proteins (see above).
Role of Mx GTPases in defending the host against highly pathogenic viruses

Enhanced virus resistance of interferontreated Mx1 +/+ animals
Human infections with currently circulating H5N1 viruses are frequently fatal and few treatment options are available to the victims. The authors therefore evaluated the protective potential of recombinant IFN-␣ in Mx1 +/+ mice. Groups of eight mice were infected with a large, lethal dose of the avian H5N1 Vietnam strain. Accordingly, the survival rate of the Mx1 +/+ mice was only 50% (Fig. 6) . However, resistance to H5N1 was greatly enhanced if the animals were treated with a single dose of exogenous IFN-␣ before infection. None of the IFN-treated Mx1 +/+ mice became severely ill and weight loss of these animals was minimal. At day three post infection, virus titres in the lungs of IFN-treated Mx1 +/+ mice were about 1,000-fold lower than titres in the lungs of Mx1 +/+ control mice treated with phosphate-buffered saline solution (PBS), demonstrating that IFN conferred very efficient protection. In contrast, the IFN treatment was completely ineffective in Mx1 -/-animals. The IFN-treated BALB/c mice died almost as quickly as the PBS-treated control mice (Fig. 6 ). Virus titres in the lung, brain and spleen were comparably high in both IFN-treated and untreated Mx1 -/-mice, indicating that Mx is indeed the major protective factor. If IFN is also beneficial when given shortly after infection, IFN treatment might be considered as an emergency measure in case of an influenza pandemic.
Viral replication fitness can out-compete the interferoninduced Mx response
All available evidence indicates that FLUAV virulence cannot be attributed to a single factor but is multi-factorial. It requires an ideal 'viral gene constellation', i.e. an optimal combination of several genetic traits (31, 37 (Fig. 6 ). In addition, hvPR8 apparently did not induce less type I IFN than comparable FLUAV strains. How, then, could hvPR8 escape the IFNinduced Mx defence mechanism? A thorough analysis, using recombinant parental and reassortant viruses (originating from hvPR8 and its standard counterpart), indicated that the high virulence resulted from extremely fast multiplication of this virus in the infected lungs. This fast growth was caused by a combination of viral genes, encoding the viral surface proteins HA and NA, and by the viral polymerase complex. It is most likely that the virus was more rapid as a result of the combined effects of:
-quick virus entry -high-speed intracellular replication -fast release.
The authors therefore suggest that rapid virus multiplication may outrun a timely antiviral response from the immunocompetent host. It is conceivable that viruses in general may take advantage of the fact that the antiviral defence system is not permanently active but requires some time to be induced and become established during infection.
Mx proteins in livestock, fish and poultry
Influenza and influenza-like viruses infect a variety of mammalian, avian and fish species and can cause serious disease in susceptible animals. Occasional devastating outbreaks in commercial stocks are known to cause huge problems and economic losses in agriculture as well as aquaculture. Therefore, the identification and characterisation of resistance traits, such as Mx, are of great interest. Indeed, Mx genes have been described in many of the important farm animals (Fig. 2) , but their significance for disease susceptibility is not yet clear. This also applies to studies on fish and avian species.
The first piscine Mx gene was identified 20 years ago in perch (Perca fluviatilis L.) (46) . Since then, Mx genes have been found in many fish species and the cloning of IFN and additional IFN-regulated genes leads to the conclusion that teleost fish possess a type I IFN system (36) . In addition, antiviral activities of some fish Mx proteins have been reported. Thus, the Mx protein of Japanese flounder (Paralichthys olivaceus) inhibits the growth of viral haemorrhagic septicaemia virus and hirame rhabdovirus (7), whereas the Mx1 protein of Atlantic salmon (Salmo salar) blocks infectious pancreatic necrosis virus and infectious salmon anaemia virus (20, 23) (Table I) . Infectious salmon anaemia virus is an orthomyxovirus, which causes disease and high mortality in farmed Atlantic salmon. Interestingly, an IFN-antagonistic infectious salmon anaemia virus protein was recently described, which appears to have a function comparable to the NS1 protein of FLUAV (27) , and thus may be responsible for viral escape from the inhibitory action of IFN-induced antiviral proteins, such as salmon Mx1.
Avian Mx proteins have the characteristic domain structure of Mx GTPases but have a unique N-terminal extension of approximately 100 amino acids (Fig. 3) . These accumulate mainly in the cytoplasm of IFN-treated cells (Fig. 4) . The genomic organisation and diversity of the chicken Mx gene was recently determined, using White Leghorn poultry (25) . Like the Mx genes of mammals, the chicken Mx gene consists of 14 exons. The chicken Mx gene promoter contains an IFN-stimulated response element (ISRE), as found in mammalian IFN-stimulated genes ( Fig. 1) (38) , indicating that the overall gene organisation and regulation of Mx genes is conserved between mammals and birds (25) . The first avian Mx protein to be characterised was from a wild duck (Anas platyrhynchos). These water birds represent a large natural reservoir of FLUAV and are expected to exhibit a high degree of innate resistance. Surprisingly, duck Mx was found to have no antiviral activity against a range of avian FLUAV when expressed from a plasmid in chicken or mouse cells (4) . Subsequent work showed that the chicken Mx protein also lacks antiviral activity against FLUAV and other viruses, when examined in a similar experimental system (6) . Therefore, recent claims of the identification of an Mx resistance allele in certain chicken lines have stirred considerable interest (21, 22) .
Mx-mediated resistance in chickens
Analyses of Mx cDNA sequences from different chicken breeds revealed a considerable number of nonsynonymous nucleotide substitutions, leading to amino acid variations (21) . Interestingly, one amino acid substitution in the chicken Mx protein was reported to cause a gain in antiviral activity. Asparagine at position 631, instead of serine, conferred antiviral activity against H5N1 FLUAV and vesicular stomatitis virus (21, 22) . As it turns out, these exciting findings were not supported by subsequent studies. Chicken Mx protein with asparagine 631 did not inhibit influenza virus replication in cultured cells, nor did it block appropriate mini-replicon systems (5) . Importantly, experimental infections of different chicken lines with a highly pathogenic H7N1 virus showed that the clinical outcome was not influenced by the proposed resistance allele (42) . The reasons for the disparity between the results of these studies are not clear at present. Nevertheless, it will be of great interest to decipher the significance of the considerable Mx polymorphism in chickens. The genetic polymorphism responsible for the S631N allelic variants was investigated extensively in various chicken lines to determine allele frequencies. The putative resistance allele was found at low frequencies in commercial broilers but at high frequencies in egg-laying lines, for unknown reasons (2). The incriminated polymorphism appears to predate chicken domestication, as it was also found in the supposed progenitor bird, the jungle fowl (39) . In view of the conflicting data discussed above, it is presumably safe to state that the recommendation to increase the frequency of the 631N allele in commercial chicken breeds is, at present, not justified. It should be noted, however, that the search for Mx resistance alleles in chickens is still incomplete.
Outlook
Outbreaks of highly pathogenic avian influenza viruses are devastating for the poultry industry. Moreover, virus transmissions from birds to humans pose a serious threat to public health. 
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Función protectora contra virus de la influenza de las GTPasas Mx inducidas por interferón
O. Haller, P. Staeheli & G. Kochs
Resumen
Las proteínas Mx son guanosina trifosfatasas (GTPasas) de gran tamaño inducidas por interferón y dotadas de actividad antivírica. Inhiben a una gran variedad de virus bloqueando las primeras etapas del ciclo de replicación. Otro aspecto importante es que también suprimen el crecimiento de virus de la influenza "A" altamente patógena, como la cepa H5N1 actualmente circulante o la cepa H1N1 causante de la pandemia de 1918. Los autores examinan las propiedades de las proteínas Mx y estudian su función en los mecanismos de defensa del huésped contra virus altamente patógenos. Además, apuntan que quizá las proteínas Mx de los mamíferos constituyan normalmente una barrera contra la transmisión zoonótica de los virus de la influenza aviar "A" y que la resistencia adquirida a la acción antivírica de la proteína humana MxA puede ser uno de los muchos factores que facilitan la propagación de cepas pandémicas en las poblaciones humanas. Los datos hoy por hoy disponibles parecen indicar que las proteínas Mx del pollo doméstico no son eficaces para combatir a los virus de la influenza aviar con capacidad comprobada para causar infecciones devastadoras en esa especie. La introducción deliberada de un gen Mx de mamífero o ave resistente dotado de actividad antivírica puede conferir cierto grado de protección e impedir que las aves criadas a escala industrial sirvan de huésped amplificador de cepas de la influenza con potencial pandémico.
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